Skip to contentLazar David E. — Zoom Telephonics, Inc. insider: 41 transactions · InsiderLensLazar David E.
- Director at Zoom Telephonics, Inc. · on record since Jan 31, 2024
- 10% owner at Zoom Telephonics, Inc. · on record since Jan 31, 2024
- Director at OPGEN INC · on record since Apr 25, 2024
- Chief Executive Officer at OPGEN INC · on record since Apr 25, 2024
- 10% owner at OPGEN INC · on record since Apr 25, 2024
- Chief Business Dev Officer at Tracon Pharmaceuticals, Inc. · on record since May 13, 2024
- Director at LQR House Inc. · on record since Nov 25, 2024
- President at LQR House Inc. · on record since Nov 25, 2024
- 10% owner at LQR House Inc. · on record since Oct 21, 2024
- 10% owner at XCYTE THERAPIES INC · on record since Feb 28, 2025
- Director at XCYTE THERAPIES INC · on record since Jan 7, 2025
- Chief Executive Officer at XCYTE THERAPIES INC · on record since Jan 7, 2025
- Director at NBC CAPITAL CORP · on record since Aug 26, 2025
- Chief Executive Officer at NBC CAPITAL CORP · on record since Aug 26, 2025
- 10% owner at NBC CAPITAL CORP · on record since Aug 26, 2025
- Director at Kala Pharmaceuticals, Inc. · on record since Nov 26, 2025
- Chief Executive Officer at Kala Pharmaceuticals, Inc. · on record since Nov 26, 2025
- Co-Chief Executive Officer at Indaptus Therapeutics, Inc. · on record since Dec 23, 2025
- Director at Indaptus Therapeutics, Inc. · on record since Mar 24, 2026
- Chief Executive Officer at MAN-GLENWOOD LEXINGTON ASSOCIATES PORTFOLIO LLC · on record since Jan 5, 2026
- Director at MAN-GLENWOOD LEXINGTON ASSOCIATES PORTFOLIO LLC · on record since Apr 2, 2026
- Director at Quantum Cyber N.V. · on record since Apr 28, 2026
- Chief Executive Officer at Quantum Cyber N.V. · on record since Apr 28, 2026
- 10% owner at Quantum Cyber N.V. · on record since Apr 28, 2026
- Director at Trafalgar Resources, Inc. · on record since May 1, 2026
- 10% owner at TITAN PHARMACEUTICALS INC · on record since Jul 8, 2022
- Director at TITAN PHARMACEUTICALS INC · on record since Jan 26, 2023
- Chief Executive Officer at TITAN PHARMACEUTICALS INC · on record since Jan 26, 2023
Insider trading activity of Lazar David E.
- Transactions on record
- 41
- since Jul 8, 2022
- Open-market buys
- 4
- $2M
- Open-market sells
- 4
- $5.9M
- Companies traded
- 11
- last filing May 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where Lazar David E. has traded
- Trafalgar Resources, Inc.1 tx · May 1, 2026
- Quantum Cyber N.V.5 tx · $3M · Apr 28, 2026
- MAN-GLENWOOD LEXINGTON ASSOCIATES PORTFOLIO LLC3 tx · $4.6M · Apr 2, 2026
- Indaptus Therapeutics, Inc.2 tx · Mar 24, 2026
- NBC CAPITAL CORP3 tx · Jan 29, 2026
- Kala Pharmaceuticals, Inc.2 tx · Dec 22, 2025
- XCYTE THERAPIES INC7 tx · $5.9M · Aug 4, 2025
- LQR House Inc.3 tx · Apr 7, 2025
- Zoom Telephonics, Inc.8 tx · $2.8M · Mar 10, 2025
Track record of Lazar David E.
Statistical track record
Free- Open-market buys
- 6
- Last buy
- Dec 26, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Lazar David E.
Co-insiders of Lazar David E.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4 tx · $350K · Aug 1, 2024
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 1, 2026 | AwardD | 1,750,000 | — | — | SEC |
| Apr 28, 2026 | AwardD | 1,000,000 | 1.50 USD | $1.5M | SEC |
| Apr 28, 2026 | AwardD | 1,000,000 | 1.50 USD | $1.5M | SEC |
| Apr 2, 2026 | Award | 5,740,000 | 0.14 USD | $819.7K | SEC |
| Apr 2, 2026 | ExerciseD | -410,000 | 2.00 USD | $820K | SEC |
| Mar 24, 2026 | SellD | -196,800 | — | — | SEC |
| Mar 24, 2026 | SellD | -700,000 | — | — | SEC |
| Mar 3, 2026 | AwardD | 1,000,000 | — | — | SEC |
| Mar 3, 2026 | AwardD | 1,000,000 | — | — | SEC |
| Mar 3, 2026 | AwardD | 1,000,000 | — | — | SEC |
| Jan 29, 2026 | Award | 6,388,000 | — | — | SEC |
| Jan 29, 2026 | ExerciseD | -39,925 | — | — | SEC |
| Jan 5, 2026 | AwardD | 1,500,000 | 2.00 USD | $3M | SEC |
| Dec 22, 2025 | OtherD | -368,614 | — | — | SEC |
| Nov 26, 2025 | AwardD | 900,000 | — | — | SEC |
| Oct 17, 2025 | SellD | -441,325 | — | — | SEC |
| Aug 4, 2025 | Sell | -6,750 | 12.36 USD | $83.4K | SEC |
| Apr 7, 2025 | Award | 100,000 | 0.00 USD | $0 | SEC |
| Mar 10, 2025 | SellD | -2,219,447 | — | — | SEC |
| Mar 10, 2025 | Award | 1,200,000 | — | — | SEC |
| Mar 10, 2025 | SellD | -2,800,000 | — | — | SEC |
| Feb 28, 2025 | ExerciseD | -1,745,262 | — | — | SEC |
| Feb 28, 2025 | Sell | -194,628,820 | 0.03 USD | $5.8M | SEC |
| Feb 28, 2025 | Exercise | 191,978,820 | — | — | SEC |
| Feb 28, 2025 | Exercise | 2,650,000 | — | — | SEC |